_id
691843fe3c536f8df2317725
Ticker
XGN
Name
Exagen Inc
Exchange
NASDAQ
Address
1261 Liberty Way, Vista, CA, United States, 92081
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.exagen.com
Description
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus platform, a cornerstone of the SLE assessment that begins by quantifying the level of CB-CAPs biomarkers (EC4d and BC4d) in the patient's blood; and AVISE APS that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE Anti-Histone, a test for autoantibodies to histone proteins; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP, a biomarker-driven RA prognostic test. Further, the company offers AVISE SLE Monitor, a blood test that employs CB-CAPs technology; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop T-Cell biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.
Last Close
7.21
Volume
150030
Current Price
7.11
Change
-1.3869625520110906
Last Updated
2025-12-05T14:03:43.165Z
Image
https://logo.clearbit.com/www.exagen.com
Ipo Date
2019-09-19T00:00:00.000Z
Market Cap
169746608
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.6667
Target Price
15.4286
Strong Buy
5
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
17244000
Cost Of Revenue
7169000
Gross Profit
10075000
Operating Expenses
13175000
Operating Income
-3100000
Interest Expense
1316000
Pretax Income
-7086000
Net Income
-7087000
Eps
-0.3089308073455699
Dividends Per Share
-
Shares Outstanding
22663099
Income Tax Expense
1000
EBITDA
-5304000
Operating Margin
-17.977267455346787
Total Other Income Expense Net
-3986000
Cash
35652000
Short Term Investments
-
Receivables
11092000
Inventories
3525000
Total Current Assets
52589000
Property Plant Equipment
9179000
Total Assets
62823000
Payables
3559000
Short Term Debt
3006000
Long Term Debt
22261000
Total Liabilities
44685000
Equity
18138000
Depreciation
612000
Change In Working Capital
5963000
Cash From Operations
2944000
Capital Expenditures
275000
Cash From Investing
-275000
Cash From Financing
2950000
Net Change In Cash
5619000
PE
-
PB
8.992520086007278
ROE
-39.0726651229463
ROA
-11.280900307212328
FCF
2669000
Fcf Percent
0.15477847367200184
Piotroski FScore
2
Health Score
27
Deep Value Investing Score
4
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
4.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
17244000
Quarters > 0 > income Statement > cost Of Revenue
7169000
Quarters > 0 > income Statement > gross Profit
10075000
Quarters > 0 > income Statement > operating Expenses
13175000
Quarters > 0 > income Statement > operating Income
-3100000
Quarters > 0 > income Statement > interest Expense
1316000
Quarters > 0 > income Statement > pretax Income
-7086000
Quarters > 0 > income Statement > net Income
-7087000
Quarters > 0 > income Statement > eps
-0.3089308073455699
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
22940412
Quarters > 0 > income Statement > income Tax Expense
1000
Quarters > 0 > income Statement > EBITDA
-5304000
Quarters > 0 > income Statement > operating Margin
-17.977267455346787
Quarters > 0 > income Statement > total Other Income Expense Net
-3986000
Quarters > 0 > balance Sheet > cash
35652000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
11092000
Quarters > 0 > balance Sheet > inventories
3525000
Quarters > 0 > balance Sheet > total Current Assets
52589000
Quarters > 0 > balance Sheet > property Plant Equipment
9179000
Quarters > 0 > balance Sheet > total Assets
62823000
Quarters > 0 > balance Sheet > payables
3559000
Quarters > 0 > balance Sheet > short Term Debt
3006000
Quarters > 0 > balance Sheet > long Term Debt
22261000
Quarters > 0 > balance Sheet > total Liabilities
44685000
Quarters > 0 > balance Sheet > equity
18138000
Quarters > 0 > cash Flow > net Income
-7087000
Quarters > 0 > cash Flow > depreciation
612000
Quarters > 0 > cash Flow > change In Working Capital
5963000
Quarters > 0 > cash Flow > cash From Operations
2944000
Quarters > 0 > cash Flow > capital Expenditures
275000
Quarters > 0 > cash Flow > cash From Investing
-275000
Quarters > 0 > cash Flow > cash From Financing
2950000
Quarters > 0 > cash Flow > net Change In Cash
5619000
Quarters > 0 > ratios > PE
-0.3089308073455699
Quarters > 0 > ratios > PB
8.992520086007278
Quarters > 0 > ratios > ROE
-39.0726651229463
Quarters > 0 > ratios > ROA
-11.280900307212328
Quarters > 0 > ratios > FCF
2669000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.15477847367200184
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
17202000
Quarters > 1 > income Statement > cost Of Revenue
6807000
Quarters > 1 > income Statement > gross Profit
10395000
Quarters > 1 > income Statement > operating Expenses
13025000
Quarters > 1 > income Statement > operating Income
-2630000
Quarters > 1 > income Statement > interest Expense
1124000
Quarters > 1 > income Statement > pretax Income
-4402000
Quarters > 1 > income Statement > net Income
-4439000
Quarters > 1 > income Statement > eps
-0.21052133362680167
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
21085749
Quarters > 1 > income Statement > income Tax Expense
37000
Quarters > 1 > income Statement > EBITDA
-2812000
Quarters > 1 > income Statement > operating Margin
-15.288919893035693
Quarters > 1 > income Statement > total Other Income Expense Net
-1772000
Quarters > 1 > balance Sheet > cash
30033000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
15404000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
50986000
Quarters > 1 > balance Sheet > property Plant Equipment
6511000
Quarters > 1 > balance Sheet > total Assets
58760000
Quarters > 1 > balance Sheet > payables
2510000
Quarters > 1 > balance Sheet > short Term Debt
1827000
Quarters > 1 > balance Sheet > long Term Debt
22310000
Quarters > 1 > balance Sheet > total Liabilities
37726000
Quarters > 1 > balance Sheet > equity
21034000
Quarters > 1 > cash Flow > net Income
-4439000
Quarters > 1 > cash Flow > depreciation
466000
Quarters > 1 > cash Flow > change In Working Capital
-1117000
Quarters > 1 > cash Flow > cash From Operations
-2885000
Quarters > 1 > cash Flow > capital Expenditures
209000
Quarters > 1 > cash Flow > cash From Investing
-209000
Quarters > 1 > cash Flow > cash From Financing
21933000
Quarters > 1 > cash Flow > net Change In Cash
18839000
Quarters > 1 > ratios > PE
-0.21052133362680167
Quarters > 1 > ratios > PB
7.127492411809452
Quarters > 1 > ratios > ROE
-21.103926975373206
Quarters > 1 > ratios > ROA
-7.554458815520762
Quarters > 1 > ratios > FCF
-3094000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.17986280665038948
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
15498000
Quarters > 2 > income Statement > cost Of Revenue
6375000
Quarters > 2 > income Statement > gross Profit
9123000
Quarters > 2 > income Statement > operating Expenses
12488000
Quarters > 2 > income Statement > operating Income
-3365000
Quarters > 2 > income Statement > interest Expense
545000
Quarters > 2 > income Statement > pretax Income
-3752000
Quarters > 2 > income Statement > net Income
-3752000
Quarters > 2 > income Statement > eps
-0.20218360448317355
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
18557390
Quarters > 2 > income Statement > income Tax Expense
-3752000
Quarters > 2 > income Statement > EBITDA
-2767000
Quarters > 2 > income Statement > operating Margin
-21.7124790295522
Quarters > 2 > income Statement > total Other Income Expense Net
-387000
Quarters > 2 > balance Sheet > cash
11194000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
14728000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
32505000
Quarters > 2 > balance Sheet > property Plant Equipment
7193000
Quarters > 2 > balance Sheet > total Assets
40294000
Quarters > 2 > balance Sheet > payables
4509000
Quarters > 2 > balance Sheet > short Term Debt
3662000
Quarters > 2 > balance Sheet > long Term Debt
18405000
Quarters > 2 > balance Sheet > total Liabilities
33891000
Quarters > 2 > balance Sheet > equity
6403000
Quarters > 2 > cash Flow > net Income
-3752000
Quarters > 2 > cash Flow > depreciation
440000
Quarters > 2 > cash Flow > change In Working Capital
-8125999
Quarters > 2 > cash Flow > cash From Operations
-10671000
Quarters > 2 > cash Flow > capital Expenditures
113000
Quarters > 2 > cash Flow > cash From Investing
-107000
Quarters > 2 > cash Flow > cash From Financing
-64000
Quarters > 2 > cash Flow > net Change In Cash
-10842000
Quarters > 2 > ratios > PE
-0.20218360448317355
Quarters > 2 > ratios > PB
20.606441183820085
Quarters > 2 > ratios > ROE
-58.59753240668437
Quarters > 2 > ratios > ROA
-9.311560033751922
Quarters > 2 > ratios > FCF
-10784000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.6958317202219642
Quarters > 2 > health Score
8
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
13655000
Quarters > 3 > income Statement > cost Of Revenue
5178000
Quarters > 3 > income Statement > gross Profit
8477000
Quarters > 3 > income Statement > operating Expenses
11860000
Quarters > 3 > income Statement > operating Income
-3383000
Quarters > 3 > income Statement > interest Expense
563000
Quarters > 3 > income Statement > pretax Income
-3749000
Quarters > 3 > income Statement > net Income
-3761000
Quarters > 3 > income Statement > eps
-0.20661379492353038
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
18203044
Quarters > 3 > income Statement > income Tax Expense
12000
Quarters > 3 > income Statement > EBITDA
-2771000
Quarters > 3 > income Statement > operating Margin
-24.774807762724276
Quarters > 3 > income Statement > total Other Income Expense Net
-366000
Quarters > 3 > balance Sheet > cash
22036000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
7835000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
36455000
Quarters > 3 > balance Sheet > property Plant Equipment
7684000
Quarters > 3 > balance Sheet > total Assets
44689000
Quarters > 3 > balance Sheet > payables
4137000
Quarters > 3 > balance Sheet > short Term Debt
1519000
Quarters > 3 > balance Sheet > long Term Debt
19822000
Quarters > 3 > balance Sheet > total Liabilities
35149000
Quarters > 3 > balance Sheet > equity
9540000
Quarters > 3 > cash Flow > net Income
-3761000
Quarters > 3 > cash Flow > depreciation
415000
Quarters > 3 > cash Flow > change In Working Capital
2936000
Quarters > 3 > cash Flow > cash From Operations
363000
Quarters > 3 > cash Flow > capital Expenditures
146000
Quarters > 3 > cash Flow > cash From Investing
-146000
Quarters > 3 > cash Flow > cash From Financing
-216000
Quarters > 3 > cash Flow > net Change In Cash
1000
Quarters > 3 > ratios > PE
-0.20661379492353038
Quarters > 3 > ratios > PB
13.566419584905661
Quarters > 3 > ratios > ROE
-39.42348008385744
Quarters > 3 > ratios > ROA
-8.415941283089797
Quarters > 3 > ratios > FCF
217000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.015891614793116075
Quarters > 3 > health Score
9
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
55641000
Annuals > 0 > income Statement > cost Of Revenue
22529000
Annuals > 0 > income Statement > gross Profit
33112000
Annuals > 0 > income Statement > operating Expenses
46748000
Annuals > 0 > income Statement > operating Income
-13636000
Annuals > 0 > income Statement > interest Expense
2234000
Annuals > 0 > income Statement > pretax Income
-15103000
Annuals > 0 > income Statement > net Income
-15115000
Annuals > 0 > income Statement > eps
-0.830355626234821
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
18203044
Annuals > 0 > income Statement > income Tax Expense
12000
Annuals > 0 > income Statement > EBITDA
-11145000
Annuals > 0 > income Statement > operating Margin
-24.507108067791737
Annuals > 0 > income Statement > total Other Income Expense Net
-1467000
Annuals > 0 > balance Sheet > cash
22036000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
7835000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
36455000
Annuals > 0 > balance Sheet > property Plant Equipment
7684000
Annuals > 0 > balance Sheet > total Assets
44689000
Annuals > 0 > balance Sheet > payables
4137000
Annuals > 0 > balance Sheet > short Term Debt
1519000
Annuals > 0 > balance Sheet > long Term Debt
19822000
Annuals > 0 > balance Sheet > total Liabilities
35149000
Annuals > 0 > balance Sheet > equity
9540000
Annuals > 0 > cash Flow > net Income
-15115000
Annuals > 0 > cash Flow > depreciation
1724000
Annuals > 0 > cash Flow > change In Working Capital
-3076000
Annuals > 0 > cash Flow > cash From Operations
-13279000
Annuals > 0 > cash Flow > capital Expenditures
515000
Annuals > 0 > cash Flow > cash From Investing
-515000
Annuals > 0 > cash Flow > cash From Financing
-663000
Annuals > 0 > cash Flow > net Change In Cash
-14457000
Annuals > 0 > ratios > PE
-0.830355626234821
Annuals > 0 > ratios > PB
14.291488423480084
Annuals > 0 > ratios > ROE
-158.43815513626836
Annuals > 0 > ratios > ROA
-33.8226409183468
Annuals > 0 > ratios > FCF
-13794000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.24791071332290937
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
52548000
Annuals > 1 > income Statement > cost Of Revenue
23092000
Annuals > 1 > income Statement > gross Profit
29456000
Annuals > 1 > income Statement > operating Expenses
52293000
Annuals > 1 > income Statement > operating Income
-22837000
Annuals > 1 > income Statement > interest Expense
2335000
Annuals > 1 > income Statement > pretax Income
-23656000
Annuals > 1 > income Statement > net Income
-23689000
Annuals > 1 > income Statement > eps
-1.3399159601361286
Annuals > 1 > income Statement > dividends Per Share
9935000
Annuals > 1 > income Statement > shares Outstanding
17679467
Annuals > 1 > income Statement > income Tax Expense
33000
Annuals > 1 > income Statement > EBITDA
-19153000
Annuals > 1 > income Statement > operating Margin
-43.45931338966278
Annuals > 1 > income Statement > total Other Income Expense Net
-819000
Annuals > 1 > balance Sheet > cash
36493000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
6551000
Annuals > 1 > balance Sheet > inventories
2871000
Annuals > 1 > balance Sheet > total Current Assets
47841000
Annuals > 1 > balance Sheet > property Plant Equipment
8487000
Annuals > 1 > balance Sheet > total Assets
56944000
Annuals > 1 > balance Sheet > payables
3131000
Annuals > 1 > balance Sheet > short Term Debt
1240000
Annuals > 1 > balance Sheet > long Term Debt
19231000
Annuals > 1 > balance Sheet > total Liabilities
34250000
Annuals > 1 > balance Sheet > equity
22694000
Annuals > 1 > cash Flow > net Income
-23689000
Annuals > 1 > cash Flow > depreciation
2168000
Annuals > 1 > cash Flow > change In Working Capital
325000
Annuals > 1 > cash Flow > cash From Operations
-14462000
Annuals > 1 > cash Flow > capital Expenditures
828000
Annuals > 1 > cash Flow > cash From Investing
-804000
Annuals > 1 > cash Flow > cash From Financing
-10632000
Annuals > 1 > cash Flow > net Change In Cash
-25898000
Annuals > 1 > ratios > PE
-1.3399159601361286
Annuals > 1 > ratios > PB
5.834987566317088
Annuals > 1 > ratios > ROE
-104.38441878910724
Annuals > 1 > ratios > ROA
-41.6005198089351
Annuals > 1 > ratios > FCF
-15290000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.29097206363705563
Annuals > 1 > health Score
19
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
45563000
Annuals > 2 > income Statement > cost Of Revenue
24214000
Annuals > 2 > income Statement > gross Profit
21349000
Annuals > 2 > income Statement > operating Expenses
67400000
Annuals > 2 > income Statement > operating Income
-46051000
Annuals > 2 > income Statement > interest Expense
2448000
Annuals > 2 > income Statement > pretax Income
-47669000
Annuals > 2 > income Statement > net Income
-47387000
Annuals > 2 > income Statement > eps
-2.774033171552295
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
17082348
Annuals > 2 > income Statement > income Tax Expense
-282000
Annuals > 2 > income Statement > EBITDA
-43664000
Annuals > 2 > income Statement > operating Margin
-101.07104448785198
Annuals > 2 > income Statement > total Other Income Expense Net
-1618000
Annuals > 2 > balance Sheet > cash
62391000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
6077000
Annuals > 2 > balance Sheet > inventories
1795000
Annuals > 2 > balance Sheet > total Current Assets
72611000
Annuals > 2 > balance Sheet > property Plant Equipment
13082000
Annuals > 2 > balance Sheet > total Assets
86221000
Annuals > 2 > balance Sheet > payables
3046000
Annuals > 2 > balance Sheet > short Term Debt
1930000
Annuals > 2 > balance Sheet > long Term Debt
28778000
Annuals > 2 > balance Sheet > total Liabilities
43761000
Annuals > 2 > balance Sheet > equity
42460000
Annuals > 2 > cash Flow > net Income
-47387000
Annuals > 2 > cash Flow > depreciation
1557000
Annuals > 2 > cash Flow > change In Working Capital
1670000
Annuals > 2 > cash Flow > cash From Operations
-32144000
Annuals > 2 > cash Flow > capital Expenditures
4318000
Annuals > 2 > cash Flow > cash From Investing
-4318000
Annuals > 2 > cash Flow > cash From Financing
-489000
Annuals > 2 > cash Flow > net Change In Cash
-36951000
Annuals > 2 > ratios > PE
-2.774033171552295
Annuals > 2 > ratios > PB
3.013348716910033
Annuals > 2 > ratios > ROE
-111.60386245878473
Annuals > 2 > ratios > ROA
-54.959928555688286
Annuals > 2 > ratios > FCF
-36462000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.8002545925421943
Annuals > 2 > health Score
19
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
48299000
Annuals > 3 > income Statement > cost Of Revenue
20588000
Annuals > 3 > income Statement > gross Profit
27711000
Annuals > 3 > income Statement > operating Expenses
51778000
Annuals > 3 > income Statement > operating Income
-24067000
Annuals > 3 > income Statement > interest Expense
2625000
Annuals > 3 > income Statement > pretax Income
-26676000
Annuals > 3 > income Statement > net Income
-26851000
Annuals > 3 > income Statement > eps
-1.681102531790124
Annuals > 3 > income Statement > dividends Per Share
390000
Annuals > 3 > income Statement > shares Outstanding
15972256
Annuals > 3 > income Statement > income Tax Expense
175000
Annuals > 3 > income Statement > EBITDA
-23103000
Annuals > 3 > income Statement > operating Margin
-49.82918901012443
Annuals > 3 > income Statement > total Other Income Expense Net
-2609000
Annuals > 3 > balance Sheet > cash
99442000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
9654000
Annuals > 3 > balance Sheet > inventories
1091000
Annuals > 3 > balance Sheet > total Current Assets
112734000
Annuals > 3 > balance Sheet > property Plant Equipment
4772000
Annuals > 3 > balance Sheet > total Assets
123445000
Annuals > 3 > balance Sheet > payables
2492000
Annuals > 3 > balance Sheet > short Term Debt
587000
Annuals > 3 > balance Sheet > long Term Debt
27478000
Annuals > 3 > balance Sheet > total Liabilities
38509000
Annuals > 3 > balance Sheet > equity
84936000
Annuals > 3 > cash Flow > net Income
-26851000
Annuals > 3 > cash Flow > depreciation
948000
Annuals > 3 > cash Flow > change In Working Capital
-61000
Annuals > 3 > cash Flow > cash From Operations
-20269000
Annuals > 3 > cash Flow > capital Expenditures
2370000
Annuals > 3 > cash Flow > cash From Investing
-2420000
Annuals > 3 > cash Flow > cash From Financing
64683000
Annuals > 3 > cash Flow > net Change In Cash
41994000
Annuals > 3 > ratios > PE
-1.681102531790124
Annuals > 3 > ratios > PB
1.4084981331826316
Annuals > 3 > ratios > ROE
-31.613214655740794
Annuals > 3 > ratios > ROA
-21.75138725748309
Annuals > 3 > ratios > FCF
-22639000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.4687260605809644
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.3089308073455699
Valuation > metrics > PB
8.992520086007278
Valuation > final Score
20
Valuation > verdict
199.8% Overvalued
Profitability > metrics > ROE
-39.0726651229463
Profitability > metrics > ROA
-13.476202247618325
Profitability > metrics > Net Margin
-0.4109835305033635
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.4636123056566324
Risk > metrics > Interest Coverage
-2.3556231003039514
Risk > final Score
9
Risk > verdict
High
Liquidity > metrics > Current Ratio
8.01051028179741
Liquidity > metrics > Quick Ratio
7.4735719725818734
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
21
Prev Risks > 1
-19
Prev Risks > 2
-18
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:38:06.290Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.1786
Earnings History > 0 > eps Difference
0.1786
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-04
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.31
Earnings History > 1 > eps Estimate
-0.16
Earnings History > 1 > eps Difference
-0.15
Earnings History > 1 > surprise Percent
-93.75
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-29
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.21
Earnings History > 2 > eps Estimate
-0.15
Earnings History > 2 > eps Difference
-0.06
Earnings History > 2 > surprise Percent
-40
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-12
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2
Earnings History > 3 > eps Estimate
-0.36
Earnings History > 3 > eps Difference
0.16
Earnings History > 3 > surprise Percent
44.4444
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-17
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.2
Earnings History > 4 > eps Estimate
-0.24
Earnings History > 4 > eps Difference
0.04
Earnings History > 4 > surprise Percent
16.6667
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.2754
Earnings History > 5 > eps Estimate
-0.29
Earnings History > 5 > eps Difference
0.0146
Earnings History > 5 > surprise Percent
5.0345
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-05
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.16
Earnings History > 6 > eps Estimate
-0.34
Earnings History > 6 > eps Difference
0.18
Earnings History > 6 > surprise Percent
52.9412
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-13
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.19
Earnings History > 7 > eps Estimate
-0.36
Earnings History > 7 > eps Difference
0.17
Earnings History > 7 > surprise Percent
47.2222
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-18
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.31
Earnings History > 8 > eps Estimate
-0.43
Earnings History > 8 > eps Difference
0.12
Earnings History > 8 > surprise Percent
27.907
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-13
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.31
Earnings History > 9 > eps Estimate
-0.47
Earnings History > 9 > eps Difference
0.16
Earnings History > 9 > surprise Percent
34.0426
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-07
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.28
Earnings History > 10 > eps Estimate
-0.49
Earnings History > 10 > eps Difference
0.21
Earnings History > 10 > surprise Percent
42.8571
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-15
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.44
Earnings History > 11 > eps Estimate
-0.56
Earnings History > 11 > eps Difference
0.12
Earnings History > 11 > surprise Percent
21.4286
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-20
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.83
Earnings History > 12 > eps Estimate
-0.78
Earnings History > 12 > eps Difference
-0.05
Earnings History > 12 > surprise Percent
-6.4103
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-14
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.47
Earnings History > 13 > eps Estimate
-0.73
Earnings History > 13 > eps Difference
0.26
Earnings History > 13 > surprise Percent
35.6164
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-04
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.78
Earnings History > 14 > eps Estimate
-0.57
Earnings History > 14 > eps Difference
-0.21
Earnings History > 14 > surprise Percent
-36.8421
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-11
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.6
Earnings History > 15 > eps Estimate
-0.61
Earnings History > 15 > eps Difference
0.01
Earnings History > 15 > surprise Percent
1.6393
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-22
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.42
Earnings History > 16 > eps Estimate
-0.5
Earnings History > 16 > eps Difference
0.08
Earnings History > 16 > surprise Percent
16
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.42
Earnings History > 17 > eps Estimate
-0.46
Earnings History > 17 > eps Difference
0.04
Earnings History > 17 > surprise Percent
8.6957
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-09
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.38
Earnings History > 18 > eps Estimate
-0.44
Earnings History > 18 > eps Difference
0.06
Earnings History > 18 > surprise Percent
13.6364
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.48
Earnings History > 19 > eps Estimate
-0.47
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-2.1277
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-16
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.27
Earnings History > 20 > eps Estimate
-0.41
Earnings History > 20 > eps Difference
0.14
Earnings History > 20 > surprise Percent
34.1463
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-10
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.34
Earnings History > 21 > eps Estimate
-0.47
Earnings History > 21 > eps Difference
0.13
Earnings History > 21 > surprise Percent
27.6596
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-07-28
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.27
Earnings History > 22 > eps Estimate
-0.76
Earnings History > 22 > eps Difference
0.49
Earnings History > 22 > surprise Percent
64.4737
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-11
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.44
Earnings History > 23 > eps Estimate
-0.49
Earnings History > 23 > eps Difference
0.05
Earnings History > 23 > surprise Percent
10.2041
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-25
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.27
Earnings History > 24 > eps Estimate
-0.37
Earnings History > 24 > eps Difference
0.1
Earnings History > 24 > surprise Percent
27.027
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-12
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-2.3
Earnings History > 25 > eps Estimate
-2.4
Earnings History > 25 > eps Difference
0.1
Earnings History > 25 > surprise Percent
4.1667
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-09-20
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-1.6
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-1.6
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2015-03-31
Earnings History > 27 > report Date
2015-05-18
Earnings History > 27 > date
2015-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.27
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.27
Earnings History > 27 > surprise Percent
-
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus platform, a cornerstone of the SLE assessment that begins by quantifying the level of CB-CAPs biomarkers (EC4d and BC4d) in the patient's blood; and AVISE APS that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE Anti-Histone, a test for autoantibodies to histone proteins; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP, a biomarker-driven RA prognostic test. Further, the company offers AVISE SLE Monitor, a blood test that employs CB-CAPs technology; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop T-Cell biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATrading the Move, Not the Narrative: (XGN) Edition news.stocktradersdaily.com
Read more →The Market Doesn't Like What It Sees From Exagen Inc.'s (NASDAQ:XGN) Revenues Yet As Shares Tumble 27% simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$15.4286
Analyst Picks
Strong Buy
5
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 48.14% of the total shares of Exagen Inc
1.
RTW INVESTMENTS, LLC(7.7118%)
since
2025/06/30
2.
The Toronto-Dominion Bank(3.8689%)
since
2025/06/30
3.
Balyasny Asset Management LLC(3.2667%)
since
2025/06/30
4.
Vanguard Group Inc(3.0978%)
since
2025/06/30
5.
Silvercrest Asset Management Group LLC(2.4167%)
since
2025/06/30
6.
Morgan Stanley - Brokerage Accounts(2.386%)
since
2025/06/30
7.
Driehaus Capital Management LLC(2.1856%)
since
2025/06/30
8.
UBS Group AG(2.0279%)
since
2025/06/30
9.
Vanguard Total Stock Mkt Idx Inv(1.9864%)
since
2025/07/31
10.
Wexford Capital LP(1.8922%)
since
2025/06/30
11.
Calamos Timpani Small Cap Growth I(1.8823%)
since
2025/07/31
12.
Timpani Small Cap Growth Equity(1.684%)
since
2025/06/30
13.
Kennedy Capital Management Inc(1.4121%)
since
2025/06/30
14.
Kennedy Micro Cap Opportunities(1.4121%)
since
2025/06/30
15.
Perkins Capital Management Inc(1.0537%)
since
2025/06/30
16.
Acadian Asset Management LLC(1.0026%)
since
2025/06/30
17.
FourWorld Capital Management LLC(0.9477%)
since
2025/06/30
18.
Manatuck Hill Partners LLC(0.7953%)
since
2025/06/30
19.
Pleiades Small Cap Equity A(0.7444%)
since
2025/06/30
20.
Silvercrest U.S. Small Cap Growth(0.696%)
since
2025/06/30
21.
Geode Capital Management, LLC(0.6657%)
since
2025/06/30
22.
Vanguard Institutional Extnd Mkt Idx Tr(0.6624%)
since
2025/07/31
23.
Point72 Asset Management, L.P.(0.6198%)
since
2025/06/30
24.
Mink Brook Asset Management LLC(0.5908%)
since
2025/06/30
25.
IMC US Ultra Micro Cap(0.4745%)
since
2025/07/31
26.
The Informed Momentum Company (formerly EAM Investors)(0.4443%)
since
2025/06/30
27.
Ameriprise Financial Inc(0.4315%)
since
2025/06/30
28.
Huntleigh Advisors Inc(0.3993%)
since
2025/06/30
29.
Fidelity Extended Market Index(0.313%)
since
2025/07/31
30.
Russell Inv US Small Cap Equity Y(0.1587%)
since
2025/07/31
31.
North Square Kennedy MicroCap I(0.117%)
since
2025/06/30
32.
Russell Inv Small Cap Fund F(0.1114%)
since
2025/07/31
33.
iShares Micro-Cap ETF(0.1078%)
since
2025/08/31
34.
Bridgeway Ultra-Small Company Market(0.1027%)
since
2025/06/30
35.
Fidelity Total Market Index(0.0992%)
since
2025/07/31
36.
Extended Equity Market Fund K(0.0881%)
since
2025/06/30
37.
Fidelity Series Total Market Index(0.0833%)
since
2025/07/31
38.
Perkins Discovery(0.075%)
since
2025/06/30
39.
Spartan Extended Market Index Pool F(0.0718%)
since
2025/07/31
40.
Fidelity Nasdaq Composite Index(0.0545%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.1786
Date
2025-09-30
EPS Actual
-0.31
EPS Estimate
-0.16
EPS Difference
-0.15
Surprise Percent
-93.75%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.